Message from the
Research Chair
|
|
|
Dear colleagues,
I hope everyone had a rested break over the summer. I’m pleased to share the latest DoM research newsletter. Thank you to all the division heads and members for taking the time to provide the information that helped populate this. As always, there are very many achievements from our researchers to celebrate and be proud of.
Vip Jairath
Professor, Medicine
Division of Gastroenterology
Associate Chair, Research, DOM
|
|
|
Photos from POEM Research Update and Networking Evening
June 4, 2024
Dr. Bosma, Trials and Tribulations
Dr. Silverman, Fecal Transplantation: New Frontiers in Medicine
|
|
|
Schulich Awards of Excellence: 2024 Winners
Schulich Award of Excellence for Faculty in Community/Distributed Sites
Dr. Ken Milne
Dr. Larry Jacobs
Schulich Faculty Mentorship Award
Dr. Michael Borrie
Dr. Ruth McManus
Continuing Medical Education Award
Dr. Sabe De
Schulich Excellence in Education Awards for Graduate/Postgraduate
Schulich Leader Award – Dr. Hari Iyer
Schulich Educator Award – Dr. Amindeep Sandhu
Dean’s Awards of Excellence for Faculty
Research and Innovation (Clinical) – Dr. Tom Appleton
|
|
|
Academic Medical Organization of Southwestern Ontario (AMOSO) Innovation Fund Recipients
Congratulations to the following 2023-2024 AMOSO Innovation Fund successful DOM applicants!
Dr. Jaspreet Bhangu (Geriatric Medicine)
Longitudinal association of cerebral blood flow and cognitive decline
$155,000 over 2 years
Drs. Lakshman Gunaratnam and Abudaker Sidahmed (Nephrology)
Unveiling a novel contributor to adverse kidney transplantation outcomes
$216,100 over 2 years
Dr. Richard Kim (Clinical Pharmacology)
Pharmacogenomics-based precision medicine for preventing severe toxicity to 5-fluorouracil based chemotherapy: Beyond simple genotype testing
$191,661 over 2 years
Drs. Alex Leligdowicz and John Basmaji (Critical Care Medicine)
Venous excess ultrasound (VEXUS)-guided fluid management versus usual care in patients with septic shock: A pilot randomized controlled trial
$89,491 over 2 years
Dr. Louise Moist (Nephrology)
Measures of Recipient Obesity predict Kidney transplant Outcomes (MOROKO) London
$208,834 over 2 years
Dr. Manuel Montero-Odasso (Geriatric Medicine)
Dementia prediction models with motor markers in mild cognitive impairment
$110,000 over 1 year
Dr. Luiz Ybarra (Cardiology)
Pre-intervention Rehabilitation to Optimize Patient Selection for Chronic Total Occlusion Percutaneous Coronary Interventions (PREHAB-CTO Study)
$200,352 over 2 years.
|
|
|
Notable Research Achievements
UWO Medicine Ranking - Best Scientists: Position in the ranking is based on each scientist’s D-index using data compiled from OpenAlex and CrossRef by December 21st 2022. The total sum for the D-index values for the best scientists in University of Western Ontario is 2,308 with a mean value for the h-index of 92.32. The total sum of publications for the best scientists in University of Western Ontario is 12,145 with the mean value for publications per scientist of 485.80.
Elsevier Top Cited Scientists: The selection is based on the top 100,000 scientists by c-score (with and without self-citations) or a percentile rank of 2% or above in the sub-field. This version (6) is based on the October 1, 2023 snapshot from Scopus, updated to end of citation year 2022.
|
|
|
Reminder – New Full-Time Statistician
This is a reminder that DOM members now have access to a full-time statistician. Dr Ebenezer Ogunsakin (PhD) has joined the Department of Medicine, Program of Experimental Medicine (POEM) in the position of full-time Statistician, adding to our existing complement of part-time statisticians.
Ebenezer has relocated to London from Edmonton where he was working for Alberta Education as an analyst. Prior to this, Ebenezer was at the School of Health Systems & Public Health, Faculty of Health Sciences, University of Pretoria, South Africa where he was a Senior Lecturer of Biostatistics and retains a cross appointment. His research interests include Bayesian statistics, spatial statistics, spatial clustering, disease mapping, environmental statistics, linear models, meta-analysis, randomized response techniques and survey methodology. Ebenezer has authored and co-authored multiple peer-reviewed scientific publications and has presented his work at many international conferences.
Ebenezer has a BSc in Statistics from the University of Ado-Ekiti in Nigeria, MSc in Statistics from the University of Ibadan in Nigeria and PhD in Statistics from the University of KwaZulu-Natal, South Africa.
To request service, please download and complete the "POEM Statistical Service and Request Form" or reach out to POEMadmin@lhsc.on.ca for assistance.
|
|
Division of Clinical Immunology and Allergy
Jeimy S, Hildebrand K, Vohra Miller S. Five things to know about measles vaccination. Canadian Medical Association Journal. In press. Accepted April 3, 2024.
Jeimy S, Chan E, Yu N, Cook V. Oral immunotherapy for treatment of food allergy in infants and preschoolers. Canadian Medical Association Journal. In press. Accepted March 11, 2024.
Jeimy S, Zhu R. Allergie à la viande rouge transmise par les tiques (syndrome α-gal). Canadian Medical Association Journal. 2024; 196(3): E108–E109.
|
|
Division of Clinical Pharmacology
Abdullah SS, Rostamzadeh N, Muanda FT, McArthur E, Weir MA, Sontrop JM, Kim RB, Kamran S, and Garg AX. High-throughput computing to automate population-based studies to detect the 30-day risk of adverse outcomes after new outpatient medication use in older adults with chronic kidney disease: A clinical research protocol. Can J Kidney Health Dis. 2024 Jan 6;11:20543581231221891. doi: 10.1177/20543581231221891.
Barrett D, Sibalija J, and Kim RB. Patients' experiences of a precision medicine clinic. J Patient Exp. 2024 Feb 1;11:23743735241229384. doi: 10.1177/23743735241229384. eCollection 2024
Medwid SJ, Mailloux JL, Wigle TJ, and Kim RB. Common dihydropyrimidinase (DPYS) genetic variations do not predict fluoropyrimidine-related chemotherapy toxicity in a Canadian cohort. Pharmacogenet Genomics. 2024 Apr 1;34(3):83–87.
Situ M, Schwarz UI, Zou G, McArthur E, Kim RB, Garg AX, and Sarma S. Does prescribing apixaban or rivaroxaban versus warfarin for patients diagnosed with atrial fibrillation save health system costs? A multivalued treatment effects analysis. Eur J Health Econ. 2024 Apr;25(3):397–409.
|
|
Division of Endocrinology and Metabolism
Berberich AJ, Hegele RA. Pancreatitis risk in genetic subtypes of multifactorial chylomicronemia syndrome.
Atherosclerosis. 2024 Mar 26:117528. doi: 10.1016/j.atherosclerosis.2024.117528.
Liu A, Van Uum S, Lee D, Hammond RR, Ezzat S, Clemens KK. A Rare Prolactin-secreting Pituitary Carcinoma With Epidural and Thecal Metastases. JCEM Case Rep. 2024 Apr 24;2(5):luae047. doi: 10.1210/jcemcr/luae047
May AK, Smeeth D, McEwen F, Moghames P, Karam E, Rieder MJ, Elzagallaai AA, van Uum S, Pluess M. Hair hormone data from Syrian refugee children: Perspectives from a two-year longitudinal study. Compr Psychoneuroendocrinol. 2024 Apr 8;18:100231. doi: 10.1016/j.cpnec.2024.100231.
Raal FJ, Hegele RA, Ruzza A, López JAG, Bhatia AK, Wu J, Wang H, Gaudet D, Wiegman A, Wang J, Santos RD. Evolocumab Treatment in Pediatric Patients With Homozygous Familial Hypercholesterolemia: Pooled Data From Three Open-Label Studies. Arterioscler Thromb Vasc Biol. 2024 May;44(5):1156-1164. doi: 10.1161/ATVBAHA.123.320268.
Sakurai R, Pieruccini-Faria F, Cornish B, Fraser J, Binns MA, Beaton D, Dilliott AA, Kwan D, Ramirez J, Tan B, Scott CJM, Sunderland KM, Tartaglia C, Finger E, Zinman L, Freedman M, McLaughlin PM, Swartz RH, Symons S, Lang AE, Bartha R, Black SE, Masellis M, Hegele RA, McIlroy W; ONDRI Investigators; Montero-Odasso M. Link among apolipoprotein E E4, gait, and cognition in neurodegenerative diseases: ONDRI study.
Alzheimers Dement. 2024 Apr;20(4):2968-2979. doi: 10.1002/alz.13740.
Yan JW, Vujcic B, Le BN, Van Aarsen K, Chen T, Halane F, Clemens KK. Predictors of 30-day recurrent emergency department visits for hyperglycemia in patients with types 1 and 2 diabetes: A population-based cohort study. CJEM. 2024 Apr 18. doi: 10.1007/s43678-024-00686-4.
|
|
Division of Gastroenterology
Choi J, Wang Q, Beaton M, Kim RB, Khanna R, Wilson A. Infliximab tissue concentrations in patients with stable ulcerative colitis are correlated with more durable infliximab-associated disease remission. Inflamm Bowel Dis. 2024 May 8:izae097. doi: 10.1093/ibd/izae097.
Iablokov V, Gregor J, Chande N, Ponich T, Jairath V, Khanna R, Asfaha S. Cannabis use in patients with inflammatory bowel disease following legalization of cannabis in Canada. Crohns Colitis 360. 2024 May 9;6(2):otae031. doi: 10.1093/crocol/otae031.
Honap S, Jairath V, Danese S, Peyrin-Biroulet L. Navigating the complexities of drug development for inflammatory bowel disease. Nat Rev Drug Discov. 2024 Jul;23(7):546-562. doi: 10.1038/s41573-024-00953-0.
Jairath V, Feagan BG, Silverberg MS, Danese S, Gionchetti P, Löwenberg M, Bressler B, Ferrante M, Hart A, Lindner D, Escher A, Jones S, Shen B, Travis S. Mucosal healing with vedolizumab in patients with chronic pouchitis: EARNEST, a randomized, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol. 2024 Jul 16:S1542-3565(24)00636-0. doi: 10.1016/j.cgh.2024.06.037.
Jairath V, Gibble TH, Moses R, Klooster B, Litcher-Kelly L, Walker M, Bernstein MC, Rupinski K, McLafferty M, Travis S, Dubinsky M. Patient interpretations of patient-reported outcome measures to assess bowel urgency: qualitative interviews in ulcerative colitis. J Patient Rep Outcomes. 2024 May 31;8(1):54. doi: 10.1186/s41687-024-00733-9.
Kahan BC, Blette BS, Harhay MO, Halpern SD, Jairath V, Copas A, Li F. Demystifying estimands in cluster-randomised trials. Stat Methods Med Res. 2024 Jul;33(7):1211-1232. doi: 10.1177/09622802241254197.
Khanna R, Feagan BG, Zou G, Stitt LW, McDonald JWD, Bressler B, Panaccione R, Shackelton LM, VanViegen T, Loftus EV Jr, Daperno M, Jairath V, D'Haens G, Sandborn WJ. Reliability and responsiveness of clinical and endoscopic outcome measures in Crohn's disease. Inflamm Bowel Dis. 2024 Apr 25:izae089. doi: 10.1093/ibd/izae089.
Ma C, Feagan BG, Wang Z, Zou G, Smith MI, Shackelton LM, Sands BE, Panaccione R, D'Haens GR, Vermeire S, Jairath V. Re-evaluating methods for assessing differences in response in ileal vs. colonic Crohn's disease: A post-hoc analysis of the FITZROY trial. J Crohns Colitis. 2024 Jul 20:jjae113. doi: 10.1093/ecco-jcc/jjae113.
Rahman S, Cipriano LE, McDonald C, Cocco S, Hindi Z, Chakraborty D, French K, Siddiqi O, Brahmania M, Wilson A, Yan B, Guizzetti L, Jairath V, Sey M. Propofol sedation does not improve measures of colonoscopy quality but increase cost - findings from a large population-based cohort study. EClinicalMedicine. 2024 Mar 9;70:102503. doi: 10.1016/j.eclinm.2024.102503.
Rieder F, Baker ME, Bruining DH, Fidler JL, Ehman EC, Sheedy SP, Heiken JP, Ream JM, Holmes DR 3rd, Inoue A, Mohammadinejad P, Lee YS, Taylor SA, Stoker J, Zou G, Wang Z, Rémillard J, Carter RE, Ottichilo R, Atkinson N, Siddiqui MT, Sunkesula VC, Ma C, Parker CE, Panés J, Rimola J, Jairath V, Feagan BG, Fletcher JG; Stenosis Therapy and Anti-Fibrosis Research (STAR) Consortium. Reliability of MR enterography features for describing fibrostenosing Crohn disease. Radiology. 2024 Aug;312(2):e233039. doi: 10.1148/radiol.233039.
Rieder F, Ma C, Hanzel J, Fletcher JG, Baker ME, Wang Z, Guizzetti L, Shackelton LM, Rémillard J, Patel M, Niu J, Ottichilo R, Santillan CS, Capozzi N, Taylor SA, Bruining DH, Zou G, Feagan BG, Jairath V, Rimola J; Stenosis Therapy and Anti-Fibrotic Research (STAR) Consortium. Reliability of CT enterography for describing fibrostenosing Crohn disease. Radiology. 2024 Aug;312(2):e233038. doi: 10.1148/radiol.233038.
Rohekar S, Boyd T, Lambert RG, Beaton M, Chande N, Gregor J, Lennox H, Mcintosh K, Ponich T, Rahman A, Sharma T, Sey M, Tauqir M, Jairath V. Initiation of vedolizumab did not provoke new-onset spondylarthritis in patients with inflammatory bowel disease: A prospective 24-week study with imaging assessments. United European Gastroenterol J. 2024 Jul 4. doi: 10.1002/ueg2.12621.
Solitano V, Siegel CA, Korzenik JR, Maratt JK, Rex DK, Maguire B, Bressler B, Grossmann J, Sedano R, McDonald JWD, Remillard J, Shackelton LM, Zou G, Feagan BG, Ma C, Jairath V. Performance of bowel preparation quality scales in patients with Crohn's disease. Aliment Pharmacol Ther. 2024 Aug 11. doi: 10.1111/apt.18210.
Wilson A, Chande N, Ponich T, Gregor JC, Choi YH, Kim RB. HLADQA1∗05G>A genetic screening promotes the safe delivery of combination therapy in inflammatory bowel disease. Clin Gastroenterol Hepatol. 2024 Apr;22(4):890-892.e2. doi: 10.1016/j.cgh.2023.08.041.
Vuyyuru SK, Ma C, Nguyen TM, Zou G, Peyrin-Biroulet L, Danese S, Dulai P, Narula N, Singh S, Jairath V. Differential efficacy of medical therapies for ulcerative colitis according to disease extent: patient-level analysis from multiple randomized controlled trials. EClinicalMedicine. 2024 May 4;72:102621. doi: 10.1016/j.eclinm.2024.102621.
Vuyyuru SK, Solitano V, Aruljothy A, Alkhattabi M, Beaton M, Gregor J, Kassam Z, Marshall H, Ramsewak D, Sedano R, Sey M, Jairath V. Prevalence of stricturing, penetrating complications and extraintestinal manifestations in inflammatory bowel disease detected on cross-sectional imaging in a tertiary care setting. United European Gastroenterol J. 2024 Jul 29. doi: 10.1002/ueg2.12635.
|
|
Division of Geriatric Medicine
Camicioli R, Morris ME, Pieruccini-Faria F, Montero-Odasso M, Son S, Buzaglo D, Hausdorff JM, Nieuwboer A. Prevention of falls in Parkinson’s disease: Guidelines and gaps. Mov Disord Clin Pract. 2023 Sep 2;10(10):1459-1469. doi: 10.1002/mdc3.13860
Carvalho de Abreu DC, Pieruccini-Faria F, Son S, Montero-Odasso M, Camicioli R. Is white matter hyperintensity burden associated with cognitive and motor impairment in patients with Parkinson’s disease? A systematic review and meta-analysis. Neurosci Biobehav Rev. 2024 Apr 16:105677. doi: 10.1016/j.neubiorev.2024.105677.
Feldman HH, Belleville S, Nygaard HB, Montero-Odasso M, Durant J, Lupo JL, Revta C, Chan S, Cuesta M, Slack PJ, Winer S, Brewster PWH, Hofer SM, Lim A, Centen A, Jacobs DM, Anderson ND, Walker JD, Speechley MR, Zou GY, Chertkow H. Protocol for the Brain Health Support Program Study of the Canadian Therapeutic Platform Trial for Multidomain Interventions to Prevent Dementia (CAN-THUMBS UP): A prospective 12-month intervention study. J Prev Alzheimers Dis. 2023;10(4):875-885. doi: 10.14283/jpad.2023.65
Fitzgibbon-Collins LK, Coombs GB, Noguchi M, Parihar S, Hughson RL, Borrie M, Peters S, Shoemaker JK, Bhangu J. Standing middle cerebral artery velocity predicts cognitive function and gait speed in older adults with cognitive impairment, and is impacted by sex differences. Cereb Circ Cogn Behav. 2024 Jan 12;6:100198. doi: 10.1016/j.cccb.2023.100198
Heckman GA, Bhangu J, Graham MM, Keen S, O'Neill DE. Geriatric Cardiology - moving beyond learning by osmosis. Can J Cardiol. 2024 Feb 28:S0828-282X(24)00183-1. doi: 10.1016/j.cjca.2024.02.018
Kim DD, Sharma AK, Anazodo U, Kertesz A, Borrie M, Lawrence KS, Singhsnaeh A, Ang LC, Finger E; Alzheimer’s Disease Neuroimaging Initiative. Longitudinal clinicoradiological findings in pathologically confirmed chronic traumatic encephalopathy. J Neurol. 2024 Mar 21. doi: 10.1007/s00415-024-12275-7
Phillips, N., Fogarty, J., Pilon, R., Whitehead, V., Best, S., Di Prospero, C., ... and Borrie, M. The Comprehensive Assessment of Neurodegeneration and Dementia (COMPASS-ND) Study neuropsychology battery of the Canadian Consortium on Neurodegeneration in Aging (CCNA): Design overview and initial validation.
Qasrawi DO, Al-Ghabkari A, Khan RM, Petrotchenko EV, Montero-Odasso M, Borchers CH. A simplified proteomics LC-MRM-MS assay for determination of apoE genotypes in plasma samples. J Proteome Res. 2024 Apr 5;23(4):1144-1149. doi: 10.1021/acs.jproteome.3c00557.
Rashidi-Ranjbar N, Churchill NW, Black SE, Kumar S, Tartaglia MC, Freedman M, Lang A, Steeves TDL, Swartz RH, Saposnik G, Sahlas D, McLaughlin P, Symons S, Strother S, Pollock BG, Rajji TK, Ozzoude M, Tan B, Arnott SR, Bartha R, Borrie M, Masellis M, Pasternak SH, Frank A, Seitz D, Ismail Z, Tang-Wai DF, Casaubon LK, Mandzia J, Jog M, Scott CJM, Dowlatshahi D, Hassan A, Grimes D, Marras C, Zamyadi M, Munoz DG, Ramirez J, Berezuk C, Holmes M, Fischer CE, Schweizer TA. Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment, cerebrovascular disease and Parkinson disease: A cross sectional and longitudinal study. Int J Geriatr Psychiatry. 2024 Mar;39(3):e6074. doi: 10.1002/gps.6074
Sakurai R, Pieruccini-Faria F, Cornish B, Fraser J, Binns MA, Beaton D, Dilliott AA, Kwan D, Ramirez J, Tan B, Scott CJM, Sunderland KM, Tartaglia C, Finger E, Zinman L, Freedman M, McLaughlin PM, Swartz RH, Symons S, Lang AE, Bartha R, Black SE, Masellis M, Hegele RA, McIlroy W; ONDRI Investigators; Montero-Odasso M. Link among apolipoprotein E E4, gait, and cognition in neurodegenerative diseases: ONDRI study. Alzheimers Dement. 2024 Apr;20(4):2968-2979. doi: 10.1002/alz.13740.
Sebastiani C, Wong JYX, Litt A, Loewen J, Reece K, Conlin N, Dunand T, Montero Odasso M, D'Amore C, Saunders S, Beauchamp M. Mapping sex and gender differences in falls among older adults: A scoping review. J Am Geriatr Soc. 2024 Mar;72(3):903-915. doi: 10.1111/jgs.18730
Subotic A, Gee M, Nelles K, Ba F, Dadar M, Duchesne S, Sharma B, Masellis M, Black SE, Almeida QJ, Smith EE, Pieruccini-Faria F, Montero-Odasso M, Camicioli R; Canadian Consortium on Neurodegeneration in Aging (CCNA). Gray matter loss relates to dual task gait in Lewy body disorders and aging. J Neurol. 2024 Feb;271(2):962-975. doi: 10.1007/s00415-023-12052-y
Sultana M, Camicioli R, Dixon RA, Whitehead S, Pieruccini-Faria F, Petrotchenko E, Speechley M, Borchers CH, Montero-Odasso M. A metabolomics analysis of a novel phenotype of older adults at higher risk of dementia. J Alzheimers Dis. 2023 Sep 28. doi: 10.3233/JAD-230683
Wittich W, Kröger E, Aubin G, Fadhlaoui A, Anderson ND, Ben Gaied N, Itzhak I, Belleville S; Canadian Consortium on Neurodegeneration (CCNA) CAN-THUMBS UP Study Group. Using co-creation focus groups to customise a remote multidomain programme designed to increase dementia literacy. BMJ Open. 2023 Sep 13;13(9):e074555. doi: 10.1136/bmjopen-2023-074555
Wong D, Bellyou M, Li A, Prado MAM, Beauchet O, Annweiler C, Montero-Odasso M, Bartha R. Magnetic resonance spectroscopy in the hippocampus of adult APP/PS1 mice following chronic vitamin D deficiency. Behav Brain Res. 2024 Feb 4;457:114713. doi: 10.1016/j.bbr.2023.114713
Xhima K, Ottoy J, Gibson E, Zukotynski K, Scott C, Feliciano GJ, Adamo S, Kuo PH, Borrie MJ, Chertkow H, Frayne R, Laforce R Jr, Noseworthy MD, Prato FS, Sahlas DJ, Smith EE, Sossi V, Thiel A, Soucy JP, Tardif JC, Goubran M, Black SE, Ramirez J; Medical Imaging Trials Network of Canada (MITNEC). Distinct spatial contributions of amyloid pathology and cerebral small vessel disease to hippocampal morphology. Alzheimers Dement. 2024 Apr 4. doi: 10.1002/alz.13791
|
|
|
Division of Hematology
Abdulrehman J, Forté S, Tomlinson G, Solh Z, Bolster L, Sun HL, Bartolucci, P, and Kuo KHM. THromboprophylaxis In Sickle Cell Disease with central venous catheters (THIS): An internal pilot randomised controlled trial protocol. BMJ Open. 2024;14(1):e079363.
Almanaseer A, Chin-Yee B, Ho J, Lazo-Langner A, Schenkel L, Bhai P, Sadikovic B, Chin-Yee IH, and Hsia CC. An approach to the investigation of thrombocytosis: Differentiating between essential thrombocythemia and secondary thrombocytosis. Advances in Hematology. 2024;2024:3056216.
Britto J, Holbrook A, Sun H, Cserti-Gazdewich C, Prokopchuk-Gauk O, Hsia C, Khamisa K, Yenson PR, Sholzberg M, Olney HJ, Shivakuma S, Jones D, Merkeley H, Costello J, Jamula E, and Arnold DM. Thrombopoietin receptor agonists and other second-line therapies for immune thrombocytopenia: A narrative review with a focus on drug access in Canada. Clinical and Investigative Medicine Medecine clinique et experimentale. 2024;47(1):13–22.
Chin-Yee B, Ho J, Sadikovic B, Chin-Yee I. Finding Goldilocks: Choosing wisely together in hematology/oncology. JCO Oncology Practice. 2024;20(2):300-2.
England JT, Szuber N, Sirhan S, Dunne T, Cerquozzi S, Hill M, Villeneuve PJA, Ho JM, Sadikovic B, Bhai P, Krishnan N, Dowhanik S, Hillis C, Capo-Chichi JM, Tsui H, Cheung V, Gauthier K, Sibai H, Davidson MB, Bankar A, Kotchetkov R, Gupta V, and Maze D. Clinical features and long-term outcomes of a pan-Canadian cohort of adolescents and young adults with myeloproliferative neoplasms: A Canadian MPN Group Study. Leukemia. 2024;38(3):570-8.
Hillyer A, Quint A, Ghassemian A, Joh-Carnella N, Knauer MJ, Dawd D, Lazo-Langner A, Mangel J, Lam S, Abdoh H, Xenocostas A, Deotare U, Saini L, Foster C, Louzada M, Ho J, Chin-Yee I, Phua CW. Serologic response to vaccine for COVID-19 in patients with hematologic malignancy: A prospective cohort study. Clinical Lymphoma, Myeloma & Leukemia. 2024;24(5):P305–315.
Ho JM, To E, Sammy R, Stoian M, Tung JM, Bodkin RJ, Cox L, Antoniou T, and Benjamin S. Outcomes of a Medication Optimization Virtual Interdisciplinary Geriatric Specialist (MOVING) Program: A feasibility study. Drugs - Real World Outcomes. 2024;11(1):117-24.
Keow J, Kwan KF, Hedley BD, Hsia CC, Xenocostas A, Chin-Yee B. Merkel cell carcinoma mimicking acute leukemia. International Journal of Laboratory Hematology. 2024 Mar 13. doi: 10.1111/ijlh.14262
Kim DDH, Popradi G, Lepic K, Paulson K, Allan D, Nampoothiri RV, Lachance S, Deotare U, White J, Elemary M, Jamani K, Fraga C, Lemieux C, Novitzky0Vasso I, Law AD, Kumar R, Walker I, Schultz KR, CTTC Chronic GVHD Guideline Working Group. Cell Therapy Transplant Canada (CTTC) consensus-based guideline 2024 for management and treatment of chronic graft-versus-host disease and future directions for development. Current Oncology. 2024;31(3):1426-44.
Liu J, Chin-Yee B, Chin-Yee IH, Ho J, Sadikovic B, Hsia CC. Sodium-glucose cotransporter-2 inhibitor-associated erythrocytosis: A retrospective cohort study. Journal of Internal Medicine. 2024;295(1):103-5.
Pope V, Hsia CC. Safe utilization of ruxolitinib in simultaneous primary myelofibrosis and warm autoimmune hemolytic anemia. Annals of Hematology. 2024;103(2):677-9.
Porres-Aguilar M, Mukherjee D, Didia SC, Lazo-Langner A. Which are the optimal thromboprophylaxis strategies for hospitalized patients with COVID-19? Current controversies. Vascular. 2024;32(1):220–5.
Santos S, Gupta A, Tinmouth A, Butt A, Berry B, Musuka C, Csert-Gazdewich C, Leung E, Duncan J, Mack J, Tan MTS, Bahmanyar M, Shehata N, Prokopchuk-Gauk O, Onell R, Nahirniak S, Covello T, Lin Y, Solh Z, Callum J, Shih AW. How do we achieve blinding in modern electronic and paper medical records during the conduct of transfusion trials? Transfusion. 2024;64(3):428-37.
Sey M, Hsia C, Jairath V. Thalidomide for bleeding from small-intestinal angiodysplasia. The New England Journal of Medicine. 2024;390(5):479-80.
Trudel S, McCurdy A, Louzada ML, Parkin S, White D, Chu MP, Kotb R, Mian H, Othman I, Su J, Khan A, Gul E, and Reece D. Belantamab mafodotin, pomalidomide and dexamethasone in refractory multiple myeloma: a phase 1/2 trial. Nature Medicine. 2024;30(2):543-51.
Wang TF, Delluc A, Cervi A, Hill D, Kovacs MJ, Séguin C, Ramsay T, and Carrier M. A survey of clinician perspectives on the management of catheter-related upper extremity deep vein thrombosis in patients with cancer. Thrombosis Research. 2024;233:10-3.
|
|
Division of Infectious Diseases
Andary CM, Al KF, Chmiel JA, Gibbons S, Daisley BA, Parvathy SN, Vareki SM, Bowdish DME, Silverman MS, Burton JP. Dissecting mechanisms of fecal microbiota transplantation efficacy in disease. Trends in Molecular Medicine. 2024;30(3): P209–222. doi: doi.org/10.1016/j.molmed.2023.12.005
Santhanam D, Chan S, Nguyen C, Racosta J, Xenacostas A, Robertson K, Silverman M. Progressive multifocal leukoencephalopathy (PML) as the presenting feature in a patient with occult low count monoclonal B lymphocytosis (LC-MBL). Journal of the Association of Medical Microbiology and Infectious Diseases. In Press.
Shuldiner J, Lacroix M, Saragosa M, Reis C, Schwartz KL, Gushue S, Leung V, Grimshaw J, Silverman M, et al. Process evaluation of two large randomized controlled trials to understand factors influencing family physicians’ use of antibiotic audit and feedback reports. BMJ. in Press
|
|
Division of Nephrology
Abdullah SS, Rostamzadeh N, Muanda FT, McArthur E, Weir MA, Sontrop JM, Kim RB, Kamran S, Garg AX. High-throughput computing to automate population-based studies to detect the 30-day risk of adverse outcomes after new outpatient medication use in older adults with chronic kidney disease: A clinical research protocol. Can J Kidney Health Dis. 2024 Jan 6;11:20543581231221891. doi:10.1177/20543581231221891.
Abidi SHR, Zincir-Heywood N, Abidi SSR, Jalakam K, Abidi S, Gunaratnam L, Suri R, Cardinale H, Vinson A, Prasad B, Walsh M, Yohanna S, Worthen G, Tennankore K. Characterizing cluster-based frailty phenotypes in a multicenter prospective cohort of kidney transplant candidates. Stud Health Technol Inform. 2024 Jan 25;310:896-900. doi: 10.3233/SHTI231094.
Alsolami E, Lotfy K, Alkhunaizi A, Cuerden M, Weir MA, House AA. Impact of donation after circulatory death on outcomes of expanded criteria donor kidney transplants. Transplant Proc. 2024 Jan-Feb;56(1):50-57. doi: 10.1016/j.transproceed.2023.11.028.
Branch A, Nuaaman MM, Appleton CT, Connaughton DM, Basmaji J, Chan TLH, Budhram A. Teaching NeuroImage: Extensive brainstem and striatal involvement in neuropsychiatric systemic lupus erythematosus. Neurology. 2024 Feb
27;102(4):e209153. doi: 10.1212/WNL.0000000000209153.
Bouzemane A, Vignot E, Derain Dubourg L, De Mul A, Molin A, Chapurlat R, Fontanges E, Delsart D, Akbari A, Huang SHS, McIntyre CW, Bacchetta J, Lemoine S. Reassuring data on the cardiovascular risk in adults with X-linked hypophosphatemia receiving conventional therapy. J Clin Endocrinol Metab. 2024 Jan 18;109(2):e488-e494. doi: 10.1210/clinem/dgad608. Erratum in: J Clin Endocrinol Metab. 2023 Dec 06.
Goldstein CE, Taljaard M, Nicholls SG, Beaucage M, Brehaut J, Cook CL, Cote BB, Craig JC, Dixon SN, Du Toit J, Du Val CCS, Garg AX, Grimshaw JM, Kalatharan S, Kim SYH, Kinsella A, Luyckx V, Weijer C. The Ottawa Statement implementation guidance document for cluster randomized trials in the hemodialysis setting. Kidney Int. 2024 May;105(5):898-911. doi: 10.1016/j.kint.2024.03.001.
Halme ALE, Roshanov PS, Tornberg SV, Lavikainen LI, Devereaux PJ, Tikkinen KAO; VISION Investigators. Timing of major postoperative bleeding among patients undergoing surgery. JAMA Netw Open. 2024 Apr 1;7(4):e244581. doi:
10.1001/jamanetworkopen.2024.4581.
Jotwani V, Thiessen-Philbrook H, Arking DE, Yang SY, McArthur E, Garg AX, Katz R, Tranah GJ, Ix JH, Cummings S, Waikar SS, Sarnak MJ, Shlipak MG, Parikh SM, Parikh CR. Association of blood mitochondrial DNA copy number with risk of acute kidney injury after cardiac surgery. Am J Kidney Dis. 2024 Apr 17:S0272-6386(24)00719-4. doi: 10.1053/j.ajkd.2024.03.013.
Kanagalingam T, Khan T, Sultan N, Cowan A, Thain J, Hoy C, Ledger S, Clemens KK. Reducing the risk of denosumab-induced hypocalcemia in patients with advanced chronic kidney disease: a quality improvement initiative. Arch Osteoporos. 2023 Nov 21;18(1):138. doi: 10.1007/s11657-023-01341-8.
Liu CW, Anih J, Lebedeva V, Gungor A, Wang C, Park L, Roshanov PS. Kidney disease in trials of perioperative tranexamic acid. J Clin Anesth. 2024 Jun;94:111417. doi: 10.1016/j.jclinane.2024.111417.
Lok CE, Hemmelgarn BR, Moist LM, Polkinghorne K, Tomlinson G, Tonelli M. Protection against Incidences of Serious Cardiovascular Events Study with daily fish oil supplementation in dialysis patients (PISCES): Protocol for a randomised controlled trial. BMJ Open. 2024 Jan 10;14(1):e072239. doi: 10.1136/bmjopen-2023-072239.
Matti D, Offerni J, Roshanov PS, Lu J, Guo Y, Lebedeva V, Ai Li E, Abed H, Luke W, Sener A, Luke PP. Canadian Anatomic Kidney Score: Quantitative macroscopic assessment of donor kidney quality for transplantation. Transplant
Direct. 2024 Mar 7;10(4):e1604. doi: 10.1097/TXD.0000000000001604.
McArthur E, Smith G, Sood MM, Blake PG, Brimble KS, Muanda FT, Garg AX, Dixon SN. Impact of the 2021 CKD-EPI eGFR equation on kidney care referral criteria in Ontario, Canada: A population-based cross-sectional study. Can J Kidney Health Dis. 2024 Mar 23;11:20543581241229258. doi: 10.1177/20543581241229258.
McIlroy DR, Feng X, Shotwell M, Wallace S, Bellomo R, Garg AX, Leslie K, Peyton P, Story D, Myles PS. Candidate kidney protective strategies for patients undergoing major abdominal surgery: a secondary analysis of the RELIEF trial
cohort. Anesthesiology. 2024 Feb 21. doi: 10.1097/ALN.0000000000004957.
McIntyre CW. Update on hemodialysis-induced multiorgan ischemia: Brains and beyond. J Am Soc Nephrol. 2024 Jan 26. doi: 10.1681/ASN.0000000000000299.
Naylor KL, Vinegar M, Blake PG, Bota S, Luo B, Garg AX, Ip J, Yeung A, Gingras J, Aziz A, Iskander C, McFarlane P. Comparison of acute health care utilization between patients receiving in-center hemodialysis and the general
population: A population-based matched cohort study from Ontario, Canada. Can J Kidney Health Dis. 2024 Mar 4;11:20543581241231426. doi: 10.1177/20543581241231426.
Roshanov PS, Khanna R. The use of placebo in clinical trials of inflammatory bowel disease. Inflamm Bowel Dis. 2024 Jan 5;30(1):156-158. doi: 10.1093/ibd/izad281.
Roshanov PS, Chan MTV, Borges FK, Conen D, Wang CY, Xavier D, Berwanger O, Marcucci M, Sessler DI, Szczeklik W, Spence J, Alonso-Coello P, Fernández C, Pearse RM, Malaga G, Garg AX, Srinathan SK, Jacka MJ, Tandon V, McGillion M, Popova E, Sigamani A, Abraham V, Biccard BM, Villar JC, Chow CK, Polanczyk CA, Tiboni M, Whitlock R, Ackland GL, Panju M, Lamy A, Sapsford R, Williams C, Wu WKK, Cortés OL, MacNeil SD, Patel A, Belley-Côté EP, Ofori S, McIntyre WF, Leong DP, Heels-Ansdell D, Gregus K, Devereaux PJ. One-year outcomes after discharge from noncardiac surgery and association between predischarge complications and death after discharge: Analysis of the VISION prospective cohort study. Anesthesiology. 2024 Jan 1;140(1):8-24. doi: 10.1097/ALN.0000000000004763.
Schott C, Colaiacovo S, Baker C, Weir MA, Connaughton DM. Reclassification of genetic testing results: A case report demonstrating the need for structured re-evaluation of genetic findings. Can J Kidney Health Dis. 2024 Apr 14;11:20543581241242562. doi: 10.1177/20543581241242562.
Tutunea-Fatan E, Arumugarajah S, Suri RS, Edgar CR, Hon I, Dikeakos JD, Gunaratnam L. Sensing dying cells in health and disease: The importance of kidney injury molecule-1. J Am Soc Nephrol. 2024 Feb 14. doi:
10.1681/ASN.0000000000000334.
Verrelli D, Sharma A, Alexiuk J, Tays Q, Rossum K, Sharma M, Ford E, Iansavitchene A, Al-Jaishi AA, Whitlock R, McIntyre CW, Garg AX, Bohm C. Effect of intradialytic exercise on cardiovascular outcomes in maintenance
hemodialysis: A systematic review and meta-analysis. Kidney360. 2024 Mar 1;5(3):390-413. doi: 10.34067/KID.0000000000000361.
Wang C, Garg AX, Luo B, Kim SJ, Knoll G, Yohanna S, Treleaven D, McKenzie S, Ip J, Cooper R, Elliott L, Naylor KL. Defining pre-emptive living kidney donor transplantation as a quality indicator. Am J Transplant. 2024 Feb 22:S1600-6135(24)00159-X. doi: 10.1016/j.ajt.2024.02.017.
Wang C, Lebedeva V, Yang J, Anih J, Park LJ, Paczkowski F, Roshanov PS. Desmopressin to reduce periprocedural bleeding and transfusion: a systematic review and meta-analysis. Perioper Med (Lond). 2024 Jan 23;13(1):5. doi:
10.1186/s13741-023-00358-4.
Willison DJ, Nash DM, Bota SE, Almadhoun S, Scassa T, Garg AX, Kidney Patient and Donor Alliance of Canada, Young A. Public and patient perspectives on the use of clinical and administrative health data to identify and contact people at
risk of future illness–The case of chronic kidney disease. PLoS One. 2024 Mar 1;19(3):e0298382. doi: 10.1371/journal.pone.0298382.
Yazdani Y, Garg AX, Zwarenstein M. Integrating specialist and primary care in chronic disease management. JAMA Intern Med. 2024 Apr 15. doi: 10.1001/jamainternmed.2024.0873.
Yohanna S, Naylor KL, Sontrop JM, Ribic CM, Clase CM, Miller MC, Madan S, Hae R, Ho J, Roushani J, Parfeniuk S, Jansen M, Shavel S, Richter M, Young K, Cowell B, Lambe S, Margetts P, Piercey K, Tandon V, Boylan C, Wang C, McKenzie S, Longo B, Garg AX. Implementation of a one-day living kidney donor assessment clinic to improve the efficiency of the living kidney donor evaluation: Program report. Can J Kidney Health Dis. 2024 Feb 25;11:20543581241231462. doi: 10.1177/20543581241231462
|
|
Division of Respirology
Khoj L, Zagà V, Amram DL, Hosein K, Pistone G, Serafini A, Bisconti M, Cammarata LM, Cattaruzza MS, Mura M. Effects of cannabis smoking on the respiratory system: a state-of-the-art review. Respiratory Medicine. 2024; 221: 107494
Palma DA, Bahig H, Hope A, Harrow S, Debenham BJ, Louie AV, Vu T, Filion E, Bezjak A, Campeau MP, Duimering A, Giuliani ME, Laba JM, Lang P, Lok BH, Qu XM, Raman S, Rodrigues GB, Goodman CD, Gaede S, Morisset J, Warner A, Dhaliwal I, Ryerson CJ. Stereotactic radiation therapy in early non–small cell lung cancer and interstitial lung disease: A nonrandomized clinical trial. JAMA Oncol. 2024 Mar 7:e237269.
Zanini U, Kalluri M, Luppi F, Kaur K, Anzani N, Franco G, Ferrara G, Mura M. Use of 6-minute walk distance to predict lung transplant-free survival in fibrosing non-IPF interstitial lung diseases. Respirology. 2024 May;29(5):387-395.
|
|
Division of Cardiology
Tianqing Peng
Skin-Like Sensing System: New Continuous Blood Pressure Measurement
New Frontiers in Research Fund – Exploration
$250,000
|
|
Division of Clinical Pharmacology
Richard B. Kim
Pharmacogenomics-based Precision Medicine for Preventing SevereToxicity to 5-Fluorouracil based Chemotherapy: Beyond Simple Genotype Testing
Academic Medical Organization of Southwestern Ontario (Funding Period: April 2024 - March 2026)
$191,661
Richard B. Kim
Organic Anion Transporter SLC22A7 is a Major Determinant of 5-Flourouracil Disposition
London Regional Cancer Program (Funding Period: January 2024 – December 2025)
$25,000
|
|
Division of Geriatric Medicine
Jaspreet Bhangu, co-investigator
Principal Site Investigator, COMPASS-ND Platform
Canadian Consortium on Neurodegeneration in Aging (CCNA) – Canadian Institute of Health Research (CIHR), 2024-2029
$1.5 million (shared part of $21 million)
Jaspreet Bhangu, principal investigator
Longitudinal association of cerebral blood flow and cognitive decline
Academic Medical Organization of Southwestern Ontario (AMOSO), 2024-2026
$155,000
Michael Borrie, principal site investigator
COMPASS-ND Platform
Canadian Consortium on Neurodegeneration in Aging (CCNA) – Canadian Institute of Health Research (CIHR), 2024-2029
$1.5 million (shared part of $21 million)
Michael Borrie, principal site investigator
ADNI-4
National Institute of Health, 2024-2029
$1.25 million (shared part of $28,125,000)
Manuel Montero-Odasso, principal investigator and platform leader
Training and Capacity Building Platform
Canadian Consortium on Neurodegeneration in Aging (CCNA) – Canadian Institute of Health Research (CIHR), 2024-2029.
$639,000 (shared part of $21 million)
Manuel Montero-Odasso, co-investigator
Preventing Falls in Older Adults: A living SR and component network MA
Canadian Institute of Health Research (CIHR), 2024-2026
$450,000
Manuel Montero-Odasso, principal investigator
Dementia Prediction Models with Motor Markers in MCI
Academic Medical Organization of Southwestern Ontario (AMOSO), 2024-2025
$110,000
Manuel Montero-Odasso, co-investigator
LIFE: A SR & MA of Lifestyle Interventions to Prevent Dementia
Canadian Institute of Health Research (CIHR), 2023-2025
$100,000
Manuel Montero-Odasso
Brain Health Care (BHCare) and Support in Aging Research Training Platform to help to build capacity and to train the next generation of leaders in research in dementia and brain health
CIHR/HRTP
$2.4 million (plus $4.8 million in matching funds form partners)
|
|
|
Hematology
Dr. Anargyros Xenocostas
A feasibility study for drug sensitivity screening of AML patients
Canadian Cancer Society Challenge Grant, 3 years
$522,474
|
|
Division of Infectious Diseases
R Rahimi and M Silverman, co-principal investigators
Metanalysis of influenza vaccine effectiveness in immunocompromised patients (investigator-initiated trial, industry)
2024 Pfizer Canada Grant, Feb 1, 2024- Feb 1, 2025
$100,000
M Silverman, co-principal investigator
Fecal Microbiota Transplantation in Combination with Immune Checkpoint Blockade in Patients with Advanced Melanoma: A Randomized Phase 2 Trial.
CIHR, 4.5 years
$2,335,045
|
|
Division of Nephrology
Lakshman Gunaratnam
Unveiling a Novel Contributor to Adverse Kidney Transplantation Outcomes
Academic Medical Organization of Southwestern Ontario (AMOSO) Innovation Fund Proposal, 2 years
$216,100
Louise Moist, with contributions from Drs. Chiu and Gunaratnam
Measures of Recipient Obesity predict Kidney transplant Outcomes (MOROKO) London
AMOSO Innovation Fund Proposal, 2 years
$208,835
Pavel Roshanov
The Inflammation REduction to Prevent cArdiovascular Injury in Renal disease (REPAIR) -1 Trial evaluating the tolerability of low dose colchicine in people with advanced kidney disease on and off maintenance dialysis
Population Health Research Institute (PHRI) Internal Grant Competition, 2 years
$154,000
|
|
Division of Respirology
Sibbald SL, Savundranayagam M, Nicholson M, Zibrowski E, Dougherty M
Learning how to breathe: Understanding experiences of patients and caregivers with lung disease
Lawson Internal Research Fund, December 2023
$19,637
|
|
Division of Endocrinology and Metabolism
Kristin Clemens
Diabetes Canada Chair in Diabetes Management
March 1, 2024, to February 28, 2029
|
|
Division of Geriatric Medicine
Manuel Montero-Odasso
2023 Impact Award, Innovation Award ($6,000), Lawson Health Research Institute and the University of Western Ontario, Canada
Awarded for a unique accomplishment in innovation for leading the World Falls Guidelines Initiative
Manuel Montero-Odasso
Elected Vice President of the World Falls Prevention Society, 2024
|
|
Division of Hematology
Uday Deotare
Promoted to Associate Professor
Chai Phua
Promoted to Associate Professor
|
|
Division of Nephrology
Chris McIntyre
John Sangster Research Award for Excellence, for his Innovation Fund project: “Using sodium MRI to understand and predict diuretic resistance: enabling precision medicine to transform the care of patients with heart failure and kidney disease.”
Pavel Roshanov
Canadian Society of Nephrology - Amgen New Investigator Lectureship 2024
|
|
Division of Clinical Immunology and Allergy
Ottawa Now – Is it time for Canada’s schools to modernize their food allergy policies?
Newstalk 580 CFRA Ottawa, March 4, 2024
Waging war on our immune systems: Immunologist explains the horrifying toll of measles
Healthydebate.ca, March 12, 2024
Setting the record straight: Medical experts debunk the biggest myths in their field
Healthydebate.ca, March 12, 2024
Food oral immunotherapy through a parent’s lens: A paradigm shift in food allergy management
Healthydebate.ca, March 26, 2024
Measles has landed in Canada and there is a flash flood of questions
The Medical Post, March 28, 2024
|
|
Division of Geriatric Medicine
How you walk and your brain health w/ Dr. Manuel Montero-Odasso
DocTalks podcast, March 7, 2024
Manuel Montero-Odasso invited to speak about his research
Taylor Podcast – Schulich Communications, April 12, 2024
|
|
Division of Infectious Diseases
HIV self-testing kits now available on campus
The Gazette, January 8, 2024
FAQ: Why are syphilis cases on the rise in Canada?
The Conversation, February 25, 2024
|
|
Division of Clinical Pharmacology
Richard B. Kim
Patient-specific prediction of fluoropyrimidine does and toxicity risk
Ontario Institute for Cancer Research (Virtual), March 7, 2024
|
|
Division of Geriatric Medicine
Michael Borrie
Research Updates
Alzheimer’s Society of Canada webinar, January 30, 2024
Manuel Montero-Odasso
Can we prevent some dementias now? Lifestyle interventions and results from the SYNERGIC Trial
Alzheimer’s Society of Canada/Canadian Consortium on Neurodegeneration in Aging Webinar, April 127, 2024
Manuel Montero-Odasso
Cognition and Falls
Uruguay Geriatric Conference, keynote speaker, October 2, 2023
|
|
Division of Infectious Diseases
Adams J, Spence C, Skinner S, and Silverman M
Infective endocarditis in women who inject drugs
Canadian Association for HIV Research, London, Ontario, April 26, 2024
Ataie L, Elsayed S, Bondy L, Devlin M, Shalhoub S, Saeed H, Mohammadi M, Silverman M, and Shahmirzadi RR
Bilateral thigh abscesses caused by Mycobacterium chelonae in the context of patient-administered testosterone injections
Association of Medical Microbiology and Infectious Diseases, Vancouver, BC, April 2024
Babaeer E, Ataie L, Ouellette D, Elsayed S, Bondy L, Devlin M, Saeed H, Mohammadi M, Silverman M, Shalhoub S, Saini LK, and Shahmirzadi RR
Case report of long-standing profound neutropenia with uncertain etiology and concomitant cutaneous fungal infection
Association of Medical Microbiology and Infectious Diseases, Vancouver, BC, April 2024
Duttagupta S, Messaoudene M, Jamal R, Mihalcioiu C, Belanger K, Lenehan J, Belkaid W, Parvathy SN, Maillou J, Hu Y, Ponce M, Hakozaki T, Méndez-Salazar EO, Silverman M, Vareki SM, Routy B, and Elkrief A.
Phase II trial of fecal microbiota transplantation in combination with first-line immune checkpoint blockade in patients with melanoma and lung cancer: interim analysis from the cutaneous melanoma arm
American Association for Cancer Research, San Diego, California, April 6, 2024
Fowler M, Bondy L, Climans S, Lau J, To E, Iordanous Y, Phung M, Fuller J, Silverman M, and Shahmirzadi RR
Unmasking complexity: Navigating the diagnostic challenge of a false-positive cryptococcal antigen in chronic meningitis with suspected indolent CNS B-cell lymphoproliferative
Association of Medical Microbiology and Infectious Diseases, Vancouver, BC, April 2024
Freitas C, Cooper C, Kroch A, Langlois MA, Arbess G, Arnold C, Benoit A, Buchan S, Chambers C, El-Helou P, Hassan H, Kendall C, Knox D, Kwong J, Loutfy M, Mah A, Moineddin R, Moqueet N, Silverman M, Tran V, Walmsley S, Yeung A, Burchell AN for the CHESS Study Team
SARS-CoV-2 Seroprevalence among People Living with HIV in Ontario: Findings from the COVID-HIV Evaluation of Serology and Health Services (CHESS) Study
Canadian Association for HIV Research, London, Ontario, April 25, 2024
Leung WF, Malhotra J, Ataie L, Elsayed S, Bondy L, Devlin M, Shalhoub S, Saeed H, Mohammadi M, Silverman M, and Rahimi R
Rapid Fire Presentations: Use of dalbavancin in treatment of acute bacterial skin and skin structure infections: Prospective case series from a Canadian perspective
Association of Medical Microbiology and Infectious Diseases, Vancouver, BC, April 2024
Leung W, Silverman M, Saeed H, Shalhoub S, and Shahmirzadi RR
Navigating the challenges: Managing mold, mycobacterial, and viral infections in a hematopoietic stem cell transplant recipient
Association of Medical Microbiology and Infectious Diseases, Vancouver, BC, April 2024
Shahmirzadi RR, Silverman M, Saeed H, Shalhoub S, and Ataie L
Cutaneous alternariosis in acute lymphocytic leukemia
Association of Medical Microbiology and Infectious Diseases, Vancouver, BC, April 2024
Shahmirzadi RR, Shojaei E, Ataie L, and Silverman M
Septic bursitis: Insights from a Canadian single-center study
Association of Medical Microbiology and Infectious Diseases, Vancouver, BC, April 2024
Thandrasisla P, Forchuk C, Anderson K, and Silverman M
Prevalence of methamphetamine/amphetamine usage and demographics of users in Ontario based on laboratory drug screen results
Canadian Association for HIV Research, London, Ontario, April 26, 2024
Thandrasisla P and Silverman M
Prevalence of methamphetamine/amphetamine usage and demographics of users in Ontario
National Institute on Drug Abuse (NIDA) International Program, Montreal, Quebec, June 15, 2024
Zhanel G, Silverman M, Malhotra J, Baxter M, Rahimi R, Leung W, Irfan N, Girouard G, Dhami R, Kucey M, Stankus V, Schmidt K, Walkty A, and Karlowsky J
IV dalbavancin usage in Canada: Results from the CLEAR Registry
Association of Medical Microbiology and Infectious Diseases, Vancouver, BC, April 2024
|
|
Division of Hematology
Dr. Gillian Mount
Joined the division as Assistant Professor
|
|
|
|
